CD117 Expression Influences Proliferation but not Survival in Canine Mammary Tumours

被引:14
作者
Brunetti, B. [1 ]
Beha, G. [1 ]
Benazzi, C. [1 ]
Bondin, V.
De Tolla, L. [2 ]
Sarli, G. [1 ]
机构
[1] Univ Bologna, Dept Vet Med Sci, I-40064 Bologna, Italy
[2] Univ Maryland, Sch Med, MSTF, Baltimore, MD 21201 USA
关键词
CD117; dog; Ki67; index; mammary tumour; C-KIT PROTOONCOGENE; PRODUCT;
D O I
10.1016/j.jcpa.2014.04.018
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD117 is a transmembrane tyrosine kinase receptor encoded by the c-Kit proto-oncogene. The immunohistochemical expression of CD117 was examined in 49 specimens of canine mammary glands (eight normal/hyperplastic, 11 benign tumours and 30 malignant tumours). Expression was assessed as: (1) presence or absence of CD117; (2) membrane, cytoplasmic, or both, distributions; and (3) percentage of CD117-labelled cells. None of these three immunohistochemical parameters was correlated with the type of mammary tissue (i.e. normal, benign or malignant), histotypes or histological stage of malignant tumours, or survival. An association was observed between Ki67 index and all three CD117 labelling parameters only for malignant tumours, with a significant increase in proliferative activity in tumours expressing CD117, mainly with both cytoplasmic and membrane expression. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 15 条
  • [1] Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues
    Chui, X
    Egami, H
    Yamashita, J
    Kurizaki, T
    Ohmachi, H
    Yamamoto, S
    Ogawa, M
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (10) : 1233 - 1236
  • [2] CD117 immunoexpression in canine mast cell tumours: Correlations with pathological variables and proliferation markers
    Da Costa R.M.G.
    Matos E.
    Rema A.
    Lopes C.
    Pires M.A.
    Gärtner F.
    [J]. BMC Veterinary Research, 3 (1)
  • [3] CANINE MAMMARY EPITHELIAL NEOPLASMS - BIOLOGIC IMPLICATIONS OF MORPHOLOGIC CHARACTERISTICS ASSESSED IN 232 DOGS
    GILBERTSON, SR
    KURZMAN, ID
    ZACHRAU, RE
    HURVITZ, AI
    BLACK, MM
    [J]. VETERINARY PATHOLOGY, 1983, 20 (02) : 127 - 142
  • [4] Study of c-kit immunoexpression in canine cutaneous melanocytic tumors
    Gomes, Joana
    Queiroga, Felisbina L.
    Prada, Justina
    Pires, Isabel
    [J]. MELANOMA RESEARCH, 2012, 22 (03) : 195 - 201
  • [5] Expression of c-kit in common benign and malignant breast lesions
    Kondi-Pafiti, Agatha
    Arkadopoulos, Nikolaos
    Gennatas, Constantinos
    Michalaki, Vassiliki
    Frangou-Plegmenou, Matrona
    Chatzipantelis, Paschalis
    [J]. TUMORI JOURNAL, 2010, 96 (06): : 978 - 984
  • [6] Frequent expression of the c-kit proto-oncogene in canine malignant mammary tumor
    Kubo, K
    Matsuyama, S
    Katayama, K
    Tsutsumi, C
    Yonezawa, K
    Shimada, T
    Kotani, T
    Sakuma, S
    Ohashi, F
    Takamori, Y
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 1998, 60 (12) : 1335 - 1340
  • [7] Misdorp W., 1999, HIST CLASSIFICATION
  • [8] Gene product (CD117) immunoreactivity in canine and feline paraffin sections
    Morini, M
    Bettini, G
    Preziosi, R
    Mandrioli, L
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 (05) : 705 - 708
  • [9] Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog
    Preziosi, R
    Morini, M
    Sarli, G
    [J]. JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2004, 16 (06) : 554 - 561
  • [10] c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer
    Regan, J. L.
    Kendrick, H.
    Magnay, F-A
    Vafaizadeh, V.
    Groner, B.
    Smalley, M. J.
    [J]. ONCOGENE, 2012, 31 (07) : 869 - 883